Read this article:
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals

Here is the original post:
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China

Follow this link:
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD

Read the original here:
Change in Number of Shares and Votes in Immunicum AB (publ)

Read the rest here:
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021

Read the original here:
Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK

Here is the original post:
Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors

Link:
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy...

View post:
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B

See the original post:
Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference

View post:
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab...

Read more from the original source:
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

More here:
Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021

Visit link:
VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and...

The rest is here:
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2...

View post:
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program

See the rest here:
Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

Go here to see the original:
Eve & Co Announces CAD$1M Private Financing

Read more here:
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update

See more here:
Medicenna Establishes At-the-Market Sales Facility